Authena, a Zug-based startup which provides a blockchain-based technology to fight product counterfeiting and the lack of transparency in supply chains, has completed a seed financing of over CHF 2.3 million from angel investors from Switzerland and the United Kingdom. The firm also received funding from Ecliptic Capital, an innovation fund focused on pre-seed, seed, and series A investments […]
Viseca, a provider of products and services in the area of cashless payment, from the issue of payment cards to the development of innovative finance management solutions, has secured a comprehensive refin
Homburger advised Credit Suisse in the tokenization of Alaïa’s shares
Homburger acted as counsel to Credit Suisse (Switzerland) regarding the tokenization of Alaïa’s existing (registered) shares and the custody of the tokenized shares. Alaïa is one of the fastest growing action sports
Invision, a private equity firm focused on succession solutions for mid-sized companies in the DACH region, is acquiring Reichelt Elektronik, an e-commerce business for electronic components distributed to B2B and B2C customers, together
Switzerland based Open Mineral has raised $33 million led by Abu Dhabi’s sovereign wealth fund, Mubadala Investment Company, to accelerate growth of its global digital trade platform for base metal commodities. Existing investors Xploration Capital
Homburger acted as counsel to finpair in its capacity as arranger in connection with the issuance of certain Schuldschein Loans to Gorilla Sports Holding. Founded in 2018 on the initiative of Norddeutsche Landesbank, finpair, a German
Bär & Karrer with Renaissance Capital in relation to Acronis common
Renaissance Capital, an investment firm with a focus on emerging markets, sponsored the repackaging transaction and acted as a dealer for the notes. E.M.I.S. Finance B.V., a Dutch limited recourse investment
Archlet, an AI-based sourcing platform startup and ETH Zürich spin-off, just closed its USD 10M Series A Financing Round. The round was led by the European venture capitalist HV Capital. The existing investors, including
ADC Therapeutics, a Lausanne-based commercial-stage oncology-focused biotechnology company, has entered into a royalty purchase agreement with HealthCare Royalty. Under the agreement, ADC Therapeutics will receive up to USD 325 million. Initial payment of USD 225 million upon
Aryzta, a global food business based in Switzerland and listed on the SIX, has entered into an underwritten agreement with three banks for a new €500 million revolving credit facility. The facility which is expected to